KR20020057085A - 미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법 - Google Patents
미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법 Download PDFInfo
- Publication number
- KR20020057085A KR20020057085A KR1020000087338A KR20000087338A KR20020057085A KR 20020057085 A KR20020057085 A KR 20020057085A KR 1020000087338 A KR1020000087338 A KR 1020000087338A KR 20000087338 A KR20000087338 A KR 20000087338A KR 20020057085 A KR20020057085 A KR 20020057085A
- Authority
- KR
- South Korea
- Prior art keywords
- salt
- gluconate
- healthful
- functional
- salt containing
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 66
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- 229910052500 inorganic mineral Inorganic materials 0.000 title abstract description 17
- 239000011707 mineral Substances 0.000 title abstract description 17
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 title abstract description 13
- 229940050410 gluconate Drugs 0.000 title abstract description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 18
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims abstract description 12
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 claims abstract description 8
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims abstract description 8
- 239000001110 calcium chloride Substances 0.000 claims abstract description 8
- 229910001628 calcium chloride Inorganic materials 0.000 claims abstract description 8
- 239000013078 crystal Substances 0.000 claims abstract description 8
- 235000012207 sodium gluconate Nutrition 0.000 claims abstract description 8
- 239000000176 sodium gluconate Substances 0.000 claims abstract description 8
- 229940005574 sodium gluconate Drugs 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229910001629 magnesium chloride Inorganic materials 0.000 claims abstract description 6
- 238000001953 recrystallisation Methods 0.000 claims abstract description 6
- 238000001816 cooling Methods 0.000 claims abstract description 5
- 238000001035 drying Methods 0.000 claims abstract description 5
- 238000010438 heat treatment Methods 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 7
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 5
- 229960001763 zinc sulfate Drugs 0.000 claims description 5
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 5
- 239000002994 raw material Substances 0.000 claims description 3
- 238000011043 electrofiltration Methods 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 235000002639 sodium chloride Nutrition 0.000 abstract description 70
- 235000010755 mineral Nutrition 0.000 abstract description 16
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 abstract description 14
- 206010020772 Hypertension Diseases 0.000 abstract description 10
- 235000011148 calcium chloride Nutrition 0.000 abstract description 7
- 235000011164 potassium chloride Nutrition 0.000 abstract description 7
- 239000001103 potassium chloride Substances 0.000 abstract description 7
- 241000186000 Bifidobacterium Species 0.000 abstract description 5
- 235000011147 magnesium chloride Nutrition 0.000 abstract description 5
- 229940099596 manganese sulfate Drugs 0.000 abstract description 4
- 239000011702 manganese sulphate Substances 0.000 abstract description 4
- 235000007079 manganese sulphate Nutrition 0.000 abstract description 4
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 abstract description 4
- 239000000706 filtrate Substances 0.000 abstract description 3
- 238000001914 filtration Methods 0.000 abstract description 3
- 210000000936 intestine Anatomy 0.000 abstract description 3
- 208000019553 vascular disease Diseases 0.000 abstract description 3
- 230000000694 effects Effects 0.000 abstract description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 238000004140 cleaning Methods 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 238000003756 stirring Methods 0.000 abstract 1
- 239000011592 zinc chloride Substances 0.000 abstract 1
- 235000005074 zinc chloride Nutrition 0.000 abstract 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 17
- 239000011780 sodium chloride Substances 0.000 description 9
- 239000000243 solution Substances 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 6
- 230000018044 dehydration Effects 0.000 description 4
- 238000006297 dehydration reaction Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000035755 proliferation Effects 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 230000005856 abnormality Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- -1 sun salt Chemical class 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N Gluconic acid Natural products OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- HCHKCACWOHOZIP-IGMARMGPSA-N Zinc-65 Chemical compound [65Zn] HCHKCACWOHOZIP-IGMARMGPSA-N 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960002713 calcium chloride Drugs 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229960002337 magnesium chloride Drugs 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 229960002816 potassium chloride Drugs 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- JBQYATWDVHIOAR-UHFFFAOYSA-N tellanylidenegermanium Chemical compound [Te]=[Ge] JBQYATWDVHIOAR-UHFFFAOYSA-N 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
- A23L27/40—Table salts; Dietetic salt substitutes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/02—Acid
- A23V2250/04—Gluconic acid
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/15—Inorganic Compounds
- A23V2250/156—Mineral combination
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/24—Heat, thermal treatment
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
생존 개체수(마리) | 사망률(%) | 혈관계 이상에 의한 사망률(%) | |
실험군 1 | 20 | 80 | 65 |
실험군 2 | 30 | 70 | 50 |
실험군 3 | 60 | 40 | 23 |
숙변의 평균 중량(g) | |
실험군 1 | 50 |
실험군 2 | 45 |
실험군 3 | 30 |
Claims (3)
- (ⅰ) 50 내지 90%(w/w)의 원료소금, 5 내지 25%(w/w)의 글루콘산 나트륨, 2 내지 12.5%(w/w)의 염화칼륨, 2 내지 12.5%(w/w)의 염화칼슘, 0.1 내지 2%(w/w)의 염화 마그네슘, 0.1 내지 2%(w/w)의 황산 아연 및 0.1 내지 1%(w/w)의 황산망간으로 구성된 원료물을 20 내지 30%(w/v)의 농도로 60 내지 80℃의 온도범위에서 가열하며 물에 용해시키는 공정;(ⅱ) 전기 용액에 0.02 내지 0.05%(w/v)의 활성탄을 가하고 교반한 후, 여과하는 공정;(ⅲ) 전기 여과액을 600 내지 700mmHg 감압조건하에서 가열농축하여 재결정핵을 생성한 후, 냉각시키고 재결정시키는 공정; 및,(ⅳ) 결정을 탈수시키고, 수분함량이 0.5%(w/w) 이하가 되도록 건조하는 공정을 포함하는, 미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법.
- 제 1항에 있어서,원료소금은 천일염, 재제염 또는 정제염인 것을 특징으로 하는미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법.
- 제 1항의 방법으로 제조된 미네랄-글루콘산염을 함유하는 기능성 소금.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0087338A KR100383389B1 (ko) | 2000-12-30 | 2000-12-30 | 미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0087338A KR100383389B1 (ko) | 2000-12-30 | 2000-12-30 | 미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20020057085A true KR20020057085A (ko) | 2002-07-11 |
KR100383389B1 KR100383389B1 (ko) | 2003-05-12 |
Family
ID=27690194
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0087338A KR100383389B1 (ko) | 2000-12-30 | 2000-12-30 | 미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100383389B1 (ko) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020090194A (ko) * | 2002-10-30 | 2002-11-30 | 도대홍 | 향기와 색소가 포집된 맛소금 제조 |
WO2004054386A1 (en) * | 2002-12-16 | 2004-07-01 | Sang-Young Park | Salt of rich minerals and production method thereof |
KR100540908B1 (ko) * | 2004-01-27 | 2006-01-11 | 하영락 | 지하 심층수를 용해수로 하는 소금 재제조 방법. |
KR100759090B1 (ko) * | 2006-02-16 | 2007-09-17 | 박상영 | 알칼리성분이 풍부한 식품첨가제 및 그 제조방법 |
KR20180021988A (ko) | 2016-08-23 | 2018-03-06 | 이원용 | 홍삼 및 견운모를 함유한 기능성 소금 및 그 제조방법 |
CN112586719A (zh) * | 2020-12-22 | 2021-04-02 | 湖北省益欣盐产业技术研究院有限公司 | 一种无钾低钠食用盐及其制备方法和应用 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101028878B1 (ko) | 2007-10-30 | 2011-04-12 | 김순동 | 해수로부터 혈압강하효과 및 높은 기능성 무기질 함량을가지는 투명한 결정화 소금 및 그의 제조방법 |
KR101466731B1 (ko) | 2014-03-27 | 2014-12-01 | (주)정진식품 | 슈가 후레이크 및 그 제조방법 |
KR101728155B1 (ko) | 2015-08-24 | 2017-04-20 | (주)영수식품 | 식이섬유를 이용한 저염소금의 제조방법 및 이에 의해 제조된 식이섬유를 이용한 저염소금 |
KR101753350B1 (ko) | 2015-08-25 | 2017-07-19 | 태현식품 | 게 또는 새우 발효물을 포함하는 기능성 천일염 및 그의 제조 방법 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03139258A (ja) * | 1989-10-20 | 1991-06-13 | Hiroyuki Akai | 塩味調味料 |
KR950002619A (ko) * | 1993-07-07 | 1995-02-16 | 조인현 | 다량의 활성광물(Active mineral) 합성시킨 식용 난염(卵鹽) |
KR0156669B1 (ko) * | 1995-07-10 | 1998-11-16 | 이기주 | 유선전화기의 수화기선 감춤장치 |
JP2002029735A (ja) * | 2000-07-14 | 2002-01-29 | Surugawan Kaiyo Shinsosui Kk | ミネラル塩製造方法 |
KR100466579B1 (ko) * | 2000-10-06 | 2005-01-15 | 조 건 식 | 키토산을 이용한 기능성 소금의 제조 방법 |
-
2000
- 2000-12-30 KR KR10-2000-0087338A patent/KR100383389B1/ko active IP Right Grant
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020090194A (ko) * | 2002-10-30 | 2002-11-30 | 도대홍 | 향기와 색소가 포집된 맛소금 제조 |
WO2004054386A1 (en) * | 2002-12-16 | 2004-07-01 | Sang-Young Park | Salt of rich minerals and production method thereof |
KR100540908B1 (ko) * | 2004-01-27 | 2006-01-11 | 하영락 | 지하 심층수를 용해수로 하는 소금 재제조 방법. |
KR100759090B1 (ko) * | 2006-02-16 | 2007-09-17 | 박상영 | 알칼리성분이 풍부한 식품첨가제 및 그 제조방법 |
KR20180021988A (ko) | 2016-08-23 | 2018-03-06 | 이원용 | 홍삼 및 견운모를 함유한 기능성 소금 및 그 제조방법 |
CN112586719A (zh) * | 2020-12-22 | 2021-04-02 | 湖北省益欣盐产业技术研究院有限公司 | 一种无钾低钠食用盐及其制备方法和应用 |
CN112586719B (zh) * | 2020-12-22 | 2022-07-15 | 湖北省益欣盐产业技术研究院有限公司 | 一种无钾低钠食用盐及其制备方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
KR100383389B1 (ko) | 2003-05-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104473120B (zh) | 一种味精的生产工艺 | |
KR100383389B1 (ko) | 미네랄-글루콘산염을 함유하는 기능성 소금의 제조방법 | |
JPH07501830A (ja) | ピルビン酸イオンの投与方法及びピルビン酸イオン前駆物質の合成方法 | |
JPH0458946B2 (ko) | ||
CN108866134B (zh) | 一种蚕蛹蛋白多肽螯合钙的制备方法 | |
CN102775340A (zh) | 以贝壳为钙源的焦谷氨酸钙合成方法 | |
JP3862295B2 (ja) | 抗肥満剤 | |
CN109761867B (zh) | 一种以羊毛脂为原料生产维生素d3的工业化新方法 | |
US4670269A (en) | Cobalt complexes and their use as nutritional supplements | |
Pfiffner et al. | Isolation and characterization of vitamin Bc from liver and yeast. 1 Occurrence of an acid-labile chick antianemia factor in liver | |
US2522854A (en) | 5, 6-dimethylbenzimidazole and acid salts thereof | |
CN108484630B (zh) | 一种盐霉素提纯方法 | |
CN1995010B (zh) | 一种合成丙酰左旋肉碱盐酸盐的方法 | |
CN111960972A (zh) | 牛磺酸镁盐及牛磺酸镁配合物的制备工艺与应用 | |
CN106866592A (zh) | 一种l‑抗坏血酸钙的制备方法 | |
EP0221096A1 (en) | COMPOSITION AND METHOD FOR PRODUCING MINERAL SALT. | |
KR100394034B1 (ko) | 용이흡수성 칼슘을 함유하는 조성물 및 그의 제조방법 | |
CN101486730A (zh) | 一种磷酸肌酸钠化合物及其合成方法 | |
JPH08291190A (ja) | ピコリン酸−クロム複合物の新たな製造方法 | |
US4196290A (en) | Method of obtaining uric acid from natural products | |
CN1065236C (zh) | 一种合成三甲铵乙内酯(甜菜碱)盐酸盐的方法 | |
JPH08103246A (ja) | ウニ由来カルシウムの製造方法ならびにこの製造方法に よって得られる易吸収性カルシウムを含有する組成物 | |
CN106631848B (zh) | 一种以海湾扇贝壳为钙源的赖氨酸螯合钙制备方法 | |
CN1172683C (zh) | 以双金属氧化物为载体的口服补硒剂及其制备与使用方法 | |
KR100985622B1 (ko) | 글루콘산을 이용한 담수진주로부터의 칼슘의 제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130425 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20140423 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20150423 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20160422 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20170425 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20180425 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20190423 Year of fee payment: 17 |